AngioDynamics Inc. (ANGO)
NASDAQ: ANGO
· Real-Time Price · USD
9.46
0.05 (0.53%)
At close: May 23, 2025, 3:59 PM
9.45
-0.05%
After-hours: May 23, 2025, 04:04 PM EDT
0.53% (1D)
Bid | 9 |
Market Cap | 383.94M |
Revenue (ttm) | 283.32M |
Net Income (ttm) | -41.39M |
EPS (ttm) | -1.01 |
PE Ratio (ttm) | -9.36 |
Forward PE | -41.63 |
Analyst | Strong Buy |
Ask | 9.57 |
Volume | 292,380 |
Avg. Volume (20D) | 498,363 |
Open | 9.27 |
Previous Close | 9.41 |
Day's Range | 9.14 - 9.46 |
52-Week Range | 5.47 - 13.50 |
Beta | 0.58 |
About ANGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
AngioDynamics Inc. is scheduled to release its earnings on Jul 15, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+12.42%
AngioDynamics shares are trading higher after the ...
Unlock content with
Pro Subscription
4 months ago
+37.66%
AngioDynamics shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 adjusted EPS guidance.

1 month ago · https://thefly.com
AngioDynamics price target raised to $16 from $15 at H.C. WainwrightH.C. Wainwright raised the firm's price target on AngioDynamics to $16 from $15 and keeps a Buy rating on the shares. The company reported a beat in fiscal Q3 and raised its fiscal 2025 guidance, the ...

1 month ago · businesswire.com
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand...